Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Yamanouchi presents novel apo B secretion inhibitors for lipoprotein disorders

July 22, 2002

Advicor marketing application submitted in Europe

July 22, 2002

Schering AG completes Leukine acquisition

July 19, 2002

NuvaRing launched as first vaginal birth control ring

July 19, 2002

New insulin secretagogues with good therapeutic profile

July 19, 2002

Potential therapeutic for diabetes YM-178 advances to phase II

July 19, 2002

Xenical label in E.U. changed to include data on overweight or obese type 2 diabetes patients

July 18, 2002

Second genomics-derived drug from HGS/GSK collaboration enters clinical testing

July 18, 2002

ETX-100 granted orphan drug designation in alpha1-antitrypsin deficiency

July 18, 2002

Janssen presents novel MTP inhibitors and their use in lipoprotein disorders

July 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 24, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
In the clinic for June 22, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Alkermes, Boehringer, Cambrian, F2G, Intrabio, Lexeo, Memo, Novocure,...